For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230718:nRSR4005Ga&default-theme=true
RNS Number : 4005G Marlowe PLC 18 July 2023
18 July 2023
Marlowe plc
Capital Reduction Effective
At a general meeting of Marlowe plc (the "Company") held on 19 June 2023 (the
"General Meeting"), a resolution was passed by shareholders to cancel the
balance standing to the credit of the share premium account of the Company, in
doing so increasing the distributable reserves of the Company by
£384,921,004.09 (the "Capital Reduction").
To be effective, the Capital Reduction required Court approval and the Company
is pleased to announce that Court approval has now been obtained and the
Capital Reduction is now effective. This follows the Court order approving the
reduction of capital which was registered with Companies House on 17 July
2023.
Whilst the Board and management remain focussed on the continued execution of
the Company's stated growth strategy, the Capital Reduction now removes a
potential restriction on the Company's ability to either make dividend
payments and other distributions or to purchase its own shares in the future.
The Capital Reduction will not change the number of Ordinary Shares in issue
or the paid up share capital of the Company or change any rights attaching to
the Ordinary Shares.
For further information:
Marlowe plc
Alex Dacre, Chief Executive www.marloweplc.com
Adam Councell, Chief Financial Officer Tel: +44 (0) 203 813 8498
Benjamin Tucker, Investor Relations Manager IR@marloweplc.com
Cenkos Securities plc (Nominated Adviser and Joint Broker)
Ben Jeynes Tel: +44 (0)20 7397 8900
George Lawson
Berenberg (Joint Broker)
Ben Wright Tel: +44 (0)20 3207 7800
Mark Whitmore
Stifel (Joint Broker)
Matthew Blawat Tel: +44 (0)20 7710 7688
Francis North
FTI Consulting
Nick Hasell Tel: +44 (0)20 3727 1340
Alex Le May
About Marlowe plc
Marlowe is a leader in business-critical services and software which assure
regulatory compliance. The company was formed to create sustainable
shareholder value through the acquisition and development of businesses that
provide regulated safety and compliance services and software. It is focused
on compliance software, eLearning, health & safety, employment law &
HR compliance, fire safety & security, water & air hygiene and
occupational health services - all of which are vital to the wellbeing of its
customers operations and are invariably governed by regulation. Marlowe
currently provides software to over 1 million users and services to over 25%
of Britain's commercial premises. The Group provides customers with a single
outsourced, nationwide, provider of a range of regulated compliance and safety
solutions. Our customers can be found in office complexes, high streets &
leisure facilities, manufacturing plants and industrial estates, and include
thousands of SMEs, local authorities, facilities management providers,
multi-site NHS trusts and FTSE 100 companies.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END MSCGPUWGMUPWGGR